MedPath
FDA Approval

Sevelamer Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Winthrop U.S, a business of sanofi-aventis U.S. LLC
DUNS: 824676584
Effective Date
December 16, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sevelamer(800 mg in 1 1)

Manufacturing Establishments4

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Reed-Lane, Inc.

Winthrop U.S, a business of sanofi-aventis U.S. LLC

001819879

EUROAPI UK LIMITED

Winthrop U.S, a business of sanofi-aventis U.S. LLC

229522842

Eurofins Biopharma Product Testing Ireland Limited

Winthrop U.S, a business of sanofi-aventis U.S. LLC

238239933

Genzyme Ireland Limited

Winthrop U.S, a business of sanofi-aventis U.S. LLC

985127419

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sevelamer Hydrochloride

Product Details

NDC Product Code
0955-1048
Application Number
NDA021179
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
December 16, 2022
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
SevelamerActive
Code: GLS2PGI8QGClass: ACTIBQuantity: 800 mg in 1 1
DIACETYLATED MONOGLYCERIDESInactive
Code: 5Z17386USFClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
© Copyright 2025. All Rights Reserved by MedPath